These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12966450)

  • 61. Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.
    Buckley MM; Sorkin EM
    Drugs; 1992 Sep; 44(3):465-97. PubMed ID: 1382939
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery.
    Drummond M; Aristides M; Davies L; Forbes C
    Br J Surg; 1994 Dec; 81(12):1742-6. PubMed ID: 7827928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
    Iorio A
    J Thromb Haemost; 2004 Jul; 2(7):1055-7. PubMed ID: 15219186
    [No Abstract]   [Full Text] [Related]  

  • 64. The role of low-molecular-weight heparins in the prevention of venous thrombosis in surgery with special reference to enoxaparin.
    Haas S
    Haemostasis; 1996; 26 Suppl 2():39-48. PubMed ID: 8707166
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The risk of venous thromboembolism in non-large-joint surgeries.
    Muntz JE
    Orthopedics; 2003 Feb; 26(2 Suppl):s237-42. PubMed ID: 12597232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism.
    Lopez LM
    Pharmacotherapy; 2001 Jun; 21(6 Pt 2):56S-61S; discussion 71S-72S. PubMed ID: 11401194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of venous thromboembolism with fondaparinux.
    Priestley M
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911134
    [No Abstract]   [Full Text] [Related]  

  • 68. Tinzaparin.
    Wong NN
    Heart Dis; 2002; 4(5):331-40. PubMed ID: 12350245
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmaco-economics and decision making in health care. The case of "Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis".
    Tarricone R
    Intern Emerg Med; 2011 Dec; 6(6):581-2. PubMed ID: 21744062
    [No Abstract]   [Full Text] [Related]  

  • 70. The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.
    Amirsadri M; Mousavi S; Karimipour A
    Daru; 2019 Dec; 27(2):627-634. PubMed ID: 31368091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery.
    Hatef DA; Kenkel JM; Nguyen MQ; Farkas JP; Abtahi F; Rohrich RJ; Brown SA
    Plast Reconstr Surg; 2008 Jul; 122(1):269-279. PubMed ID: 18594417
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.
    Noble S; Peters DH; Goa KL
    Drugs; 1995 Mar; 49(3):388-410. PubMed ID: 7774513
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Prolonged out-of-hospital prophylaxis of venous thromboembolism].
    Castells X; Vallano A
    Med Clin (Barc); 2002 Jun; 119(2):73-4. PubMed ID: 12084374
    [No Abstract]   [Full Text] [Related]  

  • 74. Delayed subdural hematoma after receiving enoxaparin for prevention of thromboembolic events from high-risk surgery.
    Willard RN; Muñiz AE; Chuidian F
    Am J Emerg Med; 2012 Jul; 30(6):1017.e5-8. PubMed ID: 21802883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Venous thrombosis and thrombophilic management of prevention and therapy].
    Ruef J; Katus HA
    Hamostaseologie; 2003 Nov; 23(4):186-98. PubMed ID: 14603383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Assessment of venous thromboembolism risk in hospitalized medical patients. Concordance between PRETEMED guide and the recommendations of the viii conference of the American College of Chest Physicians].
    Gallardo Jiménez P; Guijarro Merino R; Vallejo Herrera V; Sánchez Morales D; Villalobos Sánchez A; Perelló González-Moreno JI; Gómez-Huelgas R
    Med Clin (Barc); 2012 Nov; 139(11):467-72. PubMed ID: 22032816
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Venous thromboembolism prophylaxis after trauma: dollars and sense.
    Selby R; Geerts WH
    Crit Care Med; 2001 Sep; 29(9):1839-40. PubMed ID: 11547001
    [No Abstract]   [Full Text] [Related]  

  • 78. Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
    Tosetto A
    J Thromb Haemost; 2006 Aug; 4(8):1691-2. PubMed ID: 16879210
    [No Abstract]   [Full Text] [Related]  

  • 79. New therapeutic options in deep vein thrombosis prophylaxis.
    Eriksson BI
    Semin Hematol; 2000 Jul; 37(3 Suppl 5):7-9. PubMed ID: 11055889
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Anti-Xa activity during administration of low-molecular weight heparin in the prevention of postoperative thromboembolic complications].
    Gürlich R; Salaj P; Hrachovinová I
    Rozhl Chir; 1999 Dec; 78(12):618-21. PubMed ID: 10746083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.